Your browser doesn't support javascript.
loading
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project.
Souglakos, J; Boukovinas, I; Kakolyris, S; Xynogalos, S; Ziras, N; Athanasiadis, A; Androulakis, N; Christopoulou, A; Vaslamatzis, M; Ardavanis, A; Emmanouilides, C; Bompolaki, I; Kourousis, C; Makrantonakis, P; Christofyllakis, C; Athanasiadis, E; Kentepozidis, N; Karampeazis, A; Katopodi, U; Anagnosopoulos, A; Papadopoulos, G; Prinarakis, E; Kalisperi, A; Mavroudis, D; Georgoulias, V.
Affiliation
  • Souglakos J; Hellenic Oncology Research Group, Athens, Greece. Electronic address: johnsougl@gmail.com.
  • Boukovinas I; Hellenic Oncology Research Group, Athens, Greece.
  • Kakolyris S; Hellenic Oncology Research Group, Athens, Greece.
  • Xynogalos S; Hellenic Oncology Research Group, Athens, Greece.
  • Ziras N; Hellenic Oncology Research Group, Athens, Greece.
  • Athanasiadis A; Hellenic Oncology Research Group, Athens, Greece.
  • Androulakis N; Hellenic Oncology Research Group, Athens, Greece.
  • Christopoulou A; Hellenic Oncology Research Group, Athens, Greece.
  • Vaslamatzis M; Hellenic Oncology Research Group, Athens, Greece.
  • Ardavanis A; Hellenic Oncology Research Group, Athens, Greece.
  • Emmanouilides C; Hellenic Oncology Research Group, Athens, Greece.
  • Bompolaki I; Hellenic Oncology Research Group, Athens, Greece.
  • Kourousis C; Hellenic Oncology Research Group, Athens, Greece.
  • Makrantonakis P; Hellenic Oncology Research Group, Athens, Greece.
  • Christofyllakis C; Hellenic Oncology Research Group, Athens, Greece.
  • Athanasiadis E; Hellenic Oncology Research Group, Athens, Greece.
  • Kentepozidis N; Hellenic Oncology Research Group, Athens, Greece.
  • Karampeazis A; Hellenic Oncology Research Group, Athens, Greece.
  • Katopodi U; Hellenic Oncology Research Group, Athens, Greece.
  • Anagnosopoulos A; Hellenic Oncology Research Group, Athens, Greece.
  • Papadopoulos G; Hellenic Oncology Research Group, Athens, Greece.
  • Prinarakis E; Hellenic Oncology Research Group, Athens, Greece.
  • Kalisperi A; Hellenic Oncology Research Group, Athens, Greece.
  • Mavroudis D; Hellenic Oncology Research Group, Athens, Greece.
  • Georgoulias V; Hellenic Oncology Research Group, Athens, Greece.
Ann Oncol ; 30(8): 1304-1310, 2019 08 01.
Article in En | MEDLINE | ID: mdl-31228203
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxaloacetates / Antineoplastic Combined Chemotherapy Protocols / Colonic Neoplasms / Capecitabine / Duration of Therapy Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxaloacetates / Antineoplastic Combined Chemotherapy Protocols / Colonic Neoplasms / Capecitabine / Duration of Therapy Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: